Is OBTEF or MRK a better dividend investment in 2026?

OBTEF currently yields 2000.00% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: OBTEF offers higher current income.

What is the dividend yield difference between OBTEF and MRK?

OBTEF has a forward dividend yield of 2000.00% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 1996.75 percentage points.

Home › Compare › OBTEF vs MRK

OBTEF vs MRK: Dividend Comparison 2026

OBTEF yields 2000.00% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 OBTEF wins by $9939315158.50M in total portfolio value

INVESTMENT

TIME HORIZON10 years

OBTEF

● Live price

2000.00%

Share price

$0.10

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$9939315158.53M

Annual income

$9,049,252,674,478,578.00

Full OBTEF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — OBTEF vs MRK

📍 OBTEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	OBTEF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, OBTEF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

OBTEF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OBTEF

Annual income on $10K today (after 15% tax)

$170,000.00/yr

After 10yr DRIP, annual income (after tax)

$7,691,864,773,306,791.00/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, OBTEF beats the other by $7,691,864,773,305,983.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OBTEF + MRK for your $10,000?

OBTEF: 50%MRK: 50%

100% MRK50/50100% OBTEF

Portfolio after 10yr

$4969657579.28M

Annual income

$4,524,626,337,239,764.00/yr

Blended yield

91.05%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

OBTEF

No analyst data

Altman Z

-1.7

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OBTEF buys

MRK buys

No recent congressional trades found for OBTEF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricOBTEFMRK

Forward yield	2000.00% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$9939315158.53M ✓	$30.7K
Annual income after 10y	$9,049,252,674,478,578.00 ✓	$950.29
Total dividends collected	$9876141646.27M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: OBTEF vs MRK ($10,000, DRIP)

Year	OBTEF Portfolio	OBTEF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$210,700	$200,000.00	$11,192	$351.54	+$199.5K → OBTEF
2	$4,163,767	$3,938,317.76	$12,524	$392.70	+$4.15M → OBTEF
3	$77,191,133	$72,735,902.82	$14,015	$438.65	+$77.18M → OBTEF
4	$1,342,813,676	$1,260,219,163.76	$15,682	$489.96	+$1342.80M → OBTEF
5	$21,925,333,121	$20,488,522,486.99	$17,547	$547.23	+$21925.32M → OBTEF
6	$336,109,296,351	$312,649,189,912.21	$19,632	$611.16	+$336109.28M → OBTEF
7	$4,838,913,266,619	$4,479,276,319,522.88	$21,963	$682.53	+$4838913.24M → OBTEF
8	$65,446,276,951,058	$60,268,639,755,775.59	$24,571	$762.18	+$65446276.93M → OBTEF
9	$831,834,097,245,644	$761,806,580,908,011.90	$27,486	$851.08	+$831834097.22M → OBTEF
10	$9,939,315,158,531,418	$9,049,252,674,478,578.00	$30,745	$950.29	+$9939315158.50M → OBTEF

OBTEF vs MRK: Complete Analysis 2026

OBTEF — Stock

Orbital Corporation Limited provides integrated propulsion systems and flight critical components for tactical uncrewed aerial vehicles in Australia and the United States. It also provides modular propulsion solution, design and development, machining and prototyping, product integration, testing and validation, manufacturing and production, and servicing and support services. The company was formerly known as Orbital Engine Corporation Limited and changed its name to Orbital Corporation Limited in October 2004. Orbital Corporation Limited was incorporated in 1988 and is headquartered in Balcatta, Australia.

Full OBTEF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this OBTEF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OBTEF vs SCHD OBTEF vs JEPI OBTEF vs O OBTEF vs KO OBTEF vs MAIN OBTEF vs JNJ OBTEF vs ABBV OBTEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.